tiprankstipranks
One World Pharma Inc (OWPC)
OTHER OTC:OWPC
US Market
OWPC
One World Pharma
RESEARCH TOOLSreports

One World Pharma (OWPC) Ratios

21 Followers

One World Pharma Ratios

OWPC's free cash flow for Q3 2025 was $-7.01. For the 2025 fiscal year, OWPC's free cash flow was decreased by $ and operating cash flow was $110.55. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
 0.07 0.02 <0.01 0.04 0.33
Quick Ratio
 0.06 0.02 <0.01 0.02 0.20
Cash Ratio
 0.04 0.01 <0.01 <0.01 0.08
Solvency Ratio
 0.70 -0.39 -1.01 -0.72 -2.17
Operating Cash Flow Ratio
 -0.07 -0.35 -0.31 -0.46 -2.45
Short-Term Operating Cash Flow Coverage
 -0.08 -0.67 -0.54 -1.28 -8.17
Net Current Asset Value
$ -6.76M$ -9.91M$ -3.86M$ -4.10M$ -1.23M
Leverage Ratios
Debt-to-Assets Ratio
 0.99 54.95 22.32 0.76 0.23
Debt-to-Equity Ratio
 -14.74 -0.38 -0.59 -2.29 0.56
Debt-to-Capital Ratio
 1.07 -0.61 -1.41 1.77 0.36
Long-Term Debt-to-Capital Ratio
 1.19 -0.27 0.00 -5.94 0.14
Financial Leverage Ratio
 -14.86 >-0.01 -0.03 -3.01 2.46
Debt Service Coverage Ratio
 1.29 -0.61 -1.43 -1.08 -3.34
Interest Coverage Ratio
 -1.63 -1.71 -6.74 -2.34 -6.32
Debt to Market Cap
 273.34 1.46 0.77 0.37 0.13
Interest Debt Per Share
 0.06 0.05 0.03 0.05 0.02
Net Debt to EBITDA
 1.17 -2.21 -0.61 -1.09 -0.17
Profitability Margins
Gross Profit Margin
-675.88%80.51%-2181.22%-139.34%48.40%
EBIT Margin
10125.94%-35204.48%-48024.51%-1673.23%-8554.87%
EBITDA Margin
10574.96%-34499.86%-47572.99%-1745.04%-8449.48%
Operating Profit Margin
-1524.07%-38494.63%-27419.57%-1779.48%-8444.76%
Pretax Profit Margin
9190.67%-80917.38%-52092.78%-2434.69%-9890.66%
Net Profit Margin
9190.67%-80917.38%-52092.78%-2434.69%-9890.66%
Continuous Operations Profit Margin
9190.67%-80917.38%-52092.78%-2434.69%-9890.66%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
-603.03%210.20%189.98%136.82%117.12%
Return on Assets (ROA)
71.65%-5761.36%-3998.02%-96.58%-130.36%
Return on Equity (ROE)
-87.29%39.70%104.77%290.99%-320.84%
Return on Capital Employed (ROCE)
-33.29%60.38%55.15%-1175.23%-234.22%
Return on Invested Capital (ROIC)
-12.85%130.57%132.89%-164.69%-191.31%
Return on Tangible Assets
71.65%-5761.36%-3998.02%-96.58%-130.36%
Earnings Yield
19971.01%-152.64%-137.17%-57.78%-76.16%
Efficiency Ratios
Receivables Turnover
 1.11 4.38 1.90 10.17 0.29
Payables Turnover
 0.57 <0.01 0.33 0.38 0.04
Inventory Turnover
 5.99 0.06 0.00 5.55 0.10
Fixed Asset Turnover
 <0.01 0.00 0.00 0.09 0.04
Asset Turnover
 <0.01 0.07 0.08 0.04 0.01
Working Capital Turnover Ratio
 -0.01 >-0.01 >-0.01 -0.06 -0.03
Cash Conversion Cycle
 -256.07 -222.39K -922.47 -866.93 -3.97K
Days of Sales Outstanding
 327.55 83.31 192.10 35.89 1.24K
Days of Inventory Outstanding
 60.94 6.25K 0.00 65.72 3.67K
Days of Payables Outstanding
 644.55 228.73K 1.11K 968.54 8.88K
Operating Cycle
 388.49 6.33K 192.10 101.61 4.91K
Cash Flow Ratios
Operating Cash Flow Per Share
 >-0.01 -0.01 -0.02 -0.02 -0.06
Free Cash Flow Per Share
 >-0.01 -0.01 -0.02 -0.02 -0.07
CapEx Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.07 1.00 1.03 1.11
Dividend Paid and CapEx Coverage Ratio
 -6.44 -8.31 -236.65 -31.95 -8.20
Capital Expenditure Coverage Ratio
 -141.08K -14.96 -236.65 -31.95 -9.48
Operating Cash Flow Coverage Ratio
 -0.04 -0.30 -0.54 -0.57 -5.68
Operating Cash Flow to Sales Ratio
 -5.47 -230.65 -157.35 -10.99 -97.45
Free Cash Flow Yield
-1174.58%-46.42%-41.61%-26.89%-82.95%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 <0.01 -0.65 -0.73 -1.73 -1.31
Price-to-Sales (P/S) Ratio
 0.47 530.13 379.77 42.14 129.87
Price-to-Book (P/B) Ratio
 -0.05 -0.26 -0.76 -5.04 4.21
Price-to-Free Cash Flow (P/FCF) Ratio
 -0.09 -2.15 -2.40 -3.72 -1.21
Price-to-Operating Cash Flow Ratio
 -0.08 -2.30 -2.41 -3.84 -1.33
Price-to-Earnings Growth (PEG) Ratio
 <0.01 0.02 -0.04 0.07 0.02
Price-to-Fair Value
 -0.05 -0.26 -0.76 -5.04 4.21
Enterprise Value Multiple
 1.18 -3.75 -1.41 -3.51 -1.70
Enterprise Value
 6.42M 6.29M 5.09M 7.69M 5.51M
EV to EBITDA
 1.18 -3.75 -1.41 -3.51 -1.70
EV to Sales
 124.40 1.29K 670.54 61.22 143.90
EV to Free Cash Flow
 -22.76 -5.26 -4.24 -5.40 -1.34
EV to Operating Cash Flow
 -22.76 -5.61 -4.26 -5.57 -1.48
Tangible Book Value Per Share
 >-0.01 -0.09 -0.05 -0.02 0.02
Shareholders’ Equity Per Share
 >-0.01 -0.09 -0.05 -0.02 0.02
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Net Income Per Share
 0.04 -0.04 -0.05 -0.05 -0.06
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 0.91 2.30 1.08 1.46 1.16
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 9.17 352.85 247.87 16.06 83.88
Stock-Based Compensation to Revenue
 0.07 243.36 54.71 2.70 3.50
Income Quality
 -0.05 0.29 0.30 0.45 0.99
Currency in USD